DECEMBER 2019
OPHTHALMOLOGY
PAPER-IV
--- Content provided by FirstRanker.com ---
Please read carefully the important instructions mentioned on Page ‘1’
Answers to questions of Part A and part B are to be strictly attempted in separate answer sheets and the main + supplementary answer sheets used for each part must be tagged separately.
Answers to question(s) of Part A attempted in answer sheets of Part B or vice versa shall not be evaluated.
PART B
- a) Define dry eyes as per DEWS 2 report. 3+2+5
--- Content provided by FirstRanker.com ---
b) Role of anti-inflammatory agents in management of dry eyes.
c) Diagnosis and management of Meibomian gland disease. - a) Visual prosthesis. 5+5
b) Keratoprosthesis. - a) Ocular surface reconstruction. 4+6
--- Content provided by FirstRanker.com ---
b) SLET - Indications, intraoperative & postoperative complications and their management. - a) Bevacizumab — Mechanism of action, indications and differences with other drugs of same group. 6+4
b) Discuss in brief CATT 1 and CATT 2 trials. - Enumerate and describe role of biomarkers which may be beneficial in diagnosis, pathogenesis, treatment strategies and prevention of various ocular morbidities. 10
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
--- Content provided by FirstRanker.com ---
This download link is referred from the post: DNB 2019 June Previous Question Papers-(Diplomate of National Board) Under NBE
--- Content provided by FirstRanker.com ---